Investors Are Piling Into Nvidia Stock. But Nvidia Is Investing in 5 Other AI Stocks.The Motley Fool • 02/19/24
Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains?Zacks Investment Research • 02/16/24
Nvidia dives deeper into AI drug development with Amgen, Recursion partnershipsMarket Watch • 01/08/24
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/08/24
Recursion Pharmaceuticals (RXRX) Soars 7.4%: Is Further Upside Left in the Stock?Zacks Investment Research • 01/08/24
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery PipelineGlobeNewsWire • 01/04/24
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery IndustryGlobeNewsWire • 12/20/23
Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.The Motley Fool • 11/26/23